Shares of Genprex Inc (NASDAQ:GNPX) saw unusually-high trading volume on Tuesday . Approximately 11,638,100 shares traded hands during mid-day trading, an increase of 11,036% from the previous session’s volume of 104,505 shares.The stock last traded at $0.62 and had previously closed at $0.39.
Separately, ValuEngine upgraded shares of Genprex from a “hold” rating to a “buy” rating in a report on Thursday, August 1st.
The firm has a market cap of $6.38 million, a P/E ratio of -0.69 and a beta of 1.36. The firm’s fifty day moving average is $0.53 and its two-hundred day moving average is $1.03.
About Genprex (NASDAQ:GNPX)
Genprex, Inc operates as a clinical-stage gene therapy company. It engages in developing a new approach for treating cancer based on its novel proprietary technology platform, including initial product candidate, Oncoprex immunogene therapy. Oncoprex, which has a multimodal mechanism of action whereby it interrupts cell signaling pathways that cause replication and proliferation of cancer cells, re-establishes pathways for apoptosis in cancer cells, and modulates the immune response against cancer cells.
See Also: What is a Candlestick Chart?
Receive News & Ratings for Genprex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genprex and related companies with MarketBeat.com's FREE daily email newsletter.